Three-Pronged attack on deadly lymphoma shows promise
NCT ID NCT07457177
Summary
This study is testing whether combining three different drugs works better than current treatments for an aggressive type of blood cancer called NK/T-cell lymphoma. The trial will involve 40 adults with advanced disease who haven't had prior treatment. Researchers hope this combination will help control the cancer longer and improve survival rates for patients who currently have poor outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NK/T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.